Boland M, Tsiachristas A, Kruis A, Chavannes N, Rutten-van Mölken M. Are disease management programs for COPD cost effective. Eur Respir J.. 2012; 40:(56) Show
Bootland D, Coughlan E, Galloway R, Goubet S, McWhirter E. Critical appraisal from papers to patient: a practical guide.Boca Raton (FL): CRC Press; 2017 British Lung Foundation. Estimating the economic burden of respiratory illness in the UK. 2017. https://tinyurl.com/whj8ehmr (accessed 18 August 2021) Bunker JM, Reddel HK, Dennis SM A pragmatic cluster randomized controlled trial of early intervention for chronic obstructive pulmonary disease by practice nurse-general practitioner teams: study protocol. Implement Sci.. 2012; 7 https://doi.org/10.1186/1748-5908-7-83 Burney P, Jithoo A, Bernet K Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty-a BOLD analysis. Thorax.. 2014; 69:(5)465-473 https://doi.org/10.1186/1748-5908-7-83 Currie GP. ABC of COPD, 3rd edn. : John Wiley & Sons; 2017 Devereux G. Definition, epidemiology and risk factors, 3rd edn. : John Wiley & Sons; 2017 Department of Health and Social Care. The NHS plan: a plan for investment, a plan for reform. 2000. https://tinyurl.com/ud5fzpr4 (accessed 18 August 2021) Department of Health and Social Care. Supporting people with long term conditions. An NHS and social care model to support local innovation and integration. 2005a. https://tinyurl.com/27sk224t (accessed 18 August 2021) Department of Health and Social Care. Supporting people with long term conditions: liberating the talent of nurses who care for people with long term conditions. 2005b. https://tinyurl.com/ddup8k9b (accessed 18 August 2021) Department of Health and Social Care. National Service Framework for long term conditions. 2005c. https://tinyurl.com/yz9stvvb (accessed 18 August 2021) Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax.. 2002; 57:(10)847-852 https://doi.org/10.1136/thorax.57.10.847 Global Initiative for Chronic Obstructive Lung Disease. 2021 global strategy for the diagnosis, management and prevention of COPD. 2021. https://tinyurl.com/ck4ybdbu (accessed 18 August 2021) Guo YJ. Measurements of self-efficacy in patients with chronic kidney disease: a literature review. Nephrol Nurs J.. 2017; 44:(2)159-176 Hosseinzadeh H, Shnaigat M. Effectiveness of chronic obstructive pulmonary disease self-management interventions in primary care settings: a systematic review. Aust J Prim Health.. 2019; 25:(3)195-204 https://doi.org/10.1071/py18181 Jones R, Gruffydd-Jones K, Pinnock H Summary of the consultation on a strategy for services for chronic obstructive pulmonary disease (COPD) in England. Prim Care Respir J.. 2010; 19:S1-S17 https://doi.org/10.4104/pcrj.2010.00081 Landis SH, Muellerova H, Mannino DM Continuing to confront COPD International patient survey: COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis.. 2014; 9:597-611 https://doi.org/10.2147%2FCOPD.S61854 Murray CJ, Aravkin AY, Zheng P Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet.. 2020; 396:(10258)1223-1249 https://doi.org/10.1016/S0140-6736(20)30752-2 National Institute for Health and Care Excellence. Chronic obstructive pulmonary disease in over 16s: diagnosis and management. 2018. https://tinyurl.com/4rwtw2zs (accessed 18 August 2021) Newham JJ, Presseau J, Heslop-Marshall K Features of self-management interventions for people with COPD associated with improved health-related quality of life and reduced emergency department visits: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis.. 2017; 12 https://doi.org/10.2147%2FCOPD.S133317 Partridge MR, Dal Negro RW, Olivieri D. Understanding patients with asthma and COPD: insights from a European study. Prim Care Respir J.. 2011; 20:(3)315-323 https://doi.org/10.4104/pcrj.2011.00056 Philip J, Gold M, Brand C, Douglass J, Miller B, Sundararajan V. Negotiating hope with chronic obstructive pulmonary disease patients: a qualitative study of patients and healthcare professionals. Intern Med J.. 2012; 42:(7)816-822 https://doi.org/10.1111/j.1445-5994.2011.02641.x Pinnock H, Kendall M, Murray SA Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study. BMJ.. 2011; 342 https://doi.org/10.1136/bmj.d142 What is the most important factor the nurse can reinforce to prevent chronic Obstruction pulmonary disease COPD )?There are several things all people with COPD should do to improve their health and reduce their risk of complications. Quitting smoking — The first and most important part of any treatment plan for COPD is to stop smoking.
What are the preventions of chronic obstructive pulmonary disease?How Can COPD Be Prevented? The best way to prevent COPD is to never start smoking, and if you smoke, quit. Talk with your doctor about programs and products that can help you quit. Also, stay away from secondhand smoke, which is smoke from burning tobacco products, such as cigarettes, cigars, or pipes.
What is the main factor which contributes to the development of chronic obstructive pulmonary disease?The most significant risk factor for COPD is long-term cigarette smoking.
What is the most important intervention in chronic obstructive pulmonary disease?Smoking cessation continues to be the most important therapeutic intervention for COPD. Most patients with COPD have a history of smoking or are currently smoking tobacco products. A smoking cessation plan is an essential part of a comprehensive management plan.
|
